Accendra Health Inc 8-K, filed Jun 18, 2020
Accendra Health Inc (ACH)
8-K
2020-06-18
For: 2020-06-18
View Original
Added on
April 10, 2026
About this 8-K
Accendra Health Inc filed this 8-K on June 18, 2020.
Items reported
- Item 2.01: Completed an acquisition or sale of assets
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 18, 2020
_______________________________________________________
Owens & Minor, Inc.
(Exact name of Registrant as specified in its charter)
_______________________________________________________
Virginia | 54-1701843 | ||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||
9120 Lockwood Boulevard | Mechanicsville | Virginia | 23116 |
(Address of principal executive offices) | (Zip Code) | ||
Post Office Box 27626, Richmond, Virginia | 23261-7626 | ||
(Mailing address of principal executive offices) | (Zip Code) | ||
Registrant’s telephone number, including area code (804) 723-7000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Common Stock, $2 par value per share | OMI | New York Stock Exchange | ||
_________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 2.01 | Completion of Acquisition or Disposition of Assets. |
On June 18, 2020, Owens & Minor, Inc. (the “Company”) completed the previously announced divestiture of the Company’s Movianto business (the “Divestiture”), as well as certain support functions in the Company’s Dublin office, to Walden Group SAS (the “Buyer”) and EHDH (as Buyer’s guarantor) for cash consideration of approximately $133 million. The Company had announced its intention to sell its Movianto business as disclosed in the Company’s Current Report on Form 8-K filed on January 16, 2020, and on April 6, 2020, announced that the Company had entered into the Purchase Agreement with Buyer and Buyer’ guarantor.
Item 7.01 | Regulation FD Disclosure. |
On June 18, 2020, the Company issued a press release announcing the closing of the Divestiture. A copy of the press release is attached as Exhibit 99.1 and is being furnished pursuant to Item 7.01 of Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
OWENS & MINOR, INC. | |||||||
Date: June 18, 2020 | By: | /s/ Nicholas J. Pace | |||||
Name: | Nicholas J. Pace | ||||||
Title: | Executive Vice President, General Counsel and Corporate Secretary | ||||||
June 18, 2020
Owens & Minor Completes Sale of Movianto
Proceeds of $133 million to be used for further debt reduction
RICHMOND, Va. – Owens & Minor, Inc. (NYSE: OMI) today announced the completion of the sale of its European logistics business, Movianto, to EHDH Holding Group, one of Europe’s leading providers of healthcare logistics.
“Today’s divestiture enables Owens & Minor to concentrate focus on our strategic pillars – Products, Services and Distribution – and to continue expanding our PPE manufacturing capacity in the U.S. and North America,” said Edward A. Pesicka, President and CEO of Owens & Minor. “This transaction also contributes to the continued financial and operational strength of Owens & Minor.”
In January, Owens & Minor announced its intention to sell the European logistics business, with $133 million in proceeds from the sale to be used to further reduce company debt. In addition, on June 5, 2020, the company announced a tender offer for its outstanding senior notes due in 2021, to further improve long-term financial stability.
About Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a global healthcare solutions company with integrated technologies, products, and services aligned to deliver significant and sustained value for healthcare providers and manufacturers across the continuum of care. With approximately 15,400 dedicated teammates serving healthcare industry customers in 70 countries, Owens & Minor helps to reduce total costs across the supply chain by optimizing episode and point-of-care performance, freeing up capital and clinical resources, and managing contracts to optimize financial performance. A FORTUNE 500 company, Owens & Minor was founded in 1882 in Richmond, Virginia, where it remains headquartered today. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America.
INVESTOR CONTACT:
Chuck Graves, Director, Finance & Investor Relations, chuck.graves@owens-minor.com, 804-723-7556
SOURCE: Owens & Minor